Michael A. Rogawski, M.D., Ph.D.

Professor of Neurology and Pharmacology, University of California, Davis

Neurological Therapeutics , Drug Discovery, Epilepsy, Headache Disorders

EDUCATION

MD – Yale University

PhD – Yale University

Residency and Fellowship – Johns Hopkins Medicine

AWARDS AND ACCOLADES

Epilepsy Research Award, American Society for Pharmacology and Experimental Therapeutics

NIH Director’s Award

Neuroendocrine Research Award, American Academy of Neurology

Innovator of the Year Award, UC Davis Chancellor’s Innovation Awards

COMPANIES AND BOARDS

Co-Founder: Marinus Pharmaceuticals (NASDAQ:MRNS), Sage Therapeutics (NASDAQ:SAGE), Epalex Corporation

Scientific Advisory Board: Xenon Pharmaceuticals (NASDAQ: XENE), Zynerba Pharmaceuticals (NSADAQ:ZYNE), GW Pharmaceuticals (NASDAQ:GWPH), Zogenix (NASDAQ:ZGNX), Aquestive Therapeutics (NASDAQ:AQST)

MEMBER OF Investment Committee

Associated Portfolio Companies

No items found.